➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012836

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 012836 describes PERSANTINE, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. Additional details are available on the PERSANTINE profile page.

The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 012836
Applicant:Boehringer Ingelheim
Formulation / Manufacturing:see details
Pharmacology for NDA: 012836
Physiological EffectDecreased Platelet Aggregation
Medical Subject Heading (MeSH) Categories for 012836
Suppliers and Packaging for NDA: 012836
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERSANTINE dipyridamole TABLET;ORAL 012836 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0017 0597-0017-01 100 TABLET, COATED in 1 BOTTLE (0597-0017-01)
PERSANTINE dipyridamole TABLET;ORAL 012836 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0018 0597-0018-01 100 TABLET, COATED in 1 BOTTLE (0597-0018-01)

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Dec 22, 1986TE:ABRLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Feb 6, 1987TE:ABRLD:Yes

Profile for product number 005

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength75MG
Approval Date:Feb 6, 1987TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.